benfluorex

Known as: Benfluorexum, 1-(3-trifluoromethylphenyl)-2-[N-(2-benzoyloxyethyl)amino]propane, benfluramate 
An antilipidemic agent that decreases the relative rate of hepatic triacylglycerol synthesis. Benfluorex was never approved for use in the United… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1973-2017
0102019732017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Benfluorex was marketed in France until 2009, despite its similar pharmacological properties with fenfluramine and its… (More)
  • figure 2
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2012
2012
PURPOSE To estimate the number of deaths from valvular insufficiency caused by the use of the fenfluramine-derivative benfluorex… (More)
Is this relevant?
2010
2010
BACKGROUND Recent case reports suggest that benfluorex, a fenfluramine derivative used in the management of overweight diabetic… (More)
  • table 1
  • table 2
Is this relevant?
2010
2010
PURPOSE To evaluate and quantify in diabetic patients treated with benfluorex in France, a fenfluramine-derivated product, a… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2009
2009
Since 1976, benfluorex has been approved in Europe as a hypolipidemic and hypoglycemic drug, and is commonly used in the… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
2006
2006
The authors describe a case of valvular heart disease in a 48-year-old woman receiving benfluorex (150 mg t.i.d. for 8 years) and… (More)
Is this relevant?
2003
2003
We report the first case of valvular heart disease due to benfluorex. A 50-year-old woman who had been taking the anorectic agent… (More)
  • figure 1
  • figure 2
Is this relevant?
2003
2003
Six-month efficacy of benfluorex (Mediator) (150–450 mg/day) was assessed in a double-blind multicenter study vs. placebo or… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
1996
1996
The JCR:LA-cp rat is obese, insulin resistant, and hyperlipidemic, and the males develop atherosclerosis and ischemic myocardial… (More)
Is this relevant?
1993
1993
Insulin resistance, mainly in skeletal muscle, is linked to a cluster of prevalent diseases including NIDDM, dyslipidemias… (More)
Is this relevant?